In the Field - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

In the Field

Report From: India

September 2, 2008

Pharmaceutical Technology

Differential pricing is making more than just an appearance in Asia's pharma market these days.

Report From: Vietnam

August 2, 2008

Pharmaceutical Technology

Surrounded by competition, Vietnam's 2020 vision focuses on building a biotech sector worthy of its Asian neighbors—as well as the growing global biopharmaceutical market

Trends: Industry Job Cuts

July 2, 2008

Pharmaceutical Technology

Staff reductions are not surprising with the state of the economy and falling pharmaceutical sales.

Coming Down the Pike: Protein-Substrate Binding

July 2, 2008

Pharmaceutical Technology

Drugmakers seeking to block the activity of a protein may have a new strategy at their disposal.

Report From: The Netherlands

July 2, 2008

Pharmaceutical Technology

A growing preference for public-private partnerships is spurring innovation and technology among Dutch pharmaceutical companies.

Report from: India

June 2, 2008

Pharmaceutical Technology

With rising drug deveopment costs and burdensome clinical trials, Indian-based firms are transferring their research departments to other entities in hopes of saving cash, mitigating risk, and ultimately, buying back the rewards.

Coming Down the Pike: Endocannabinoids

June 2, 2008

Pharmaceutical Technology

Scientists are uncovering signaling systems that operate via cannabinoid messenger molecules.

Report from Europe

May 2, 2008

Pharmaceutical Technology

With counterfeiting on the rise and Europeans worried their backyard is becoming a base for such illegal activity, legislators have proposed a series of solutions that span the continent and abroad.

Market Watch: Japan

May 2, 2008

Pharmaceutical Technology

According to the latest figures from IMS Health, Inc., Japan's pharmaceutical market is expected to grow 1–2% this year compared to global industry growth expectations of 5–6%.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What impact do mega-mergers of biopharmaceutical companies have on the development of new drugs?
Improves the quality and number of innovative drugs available to patients.
Restricts innovation and the development of new drugs.
Has no impact on drug development.
Do not know.
Improves the quality and number of innovative drugs available to patients.
29%
Restricts innovation and the development of new drugs.
54%
Has no impact on drug development.
4%
Do not know.
13%
Eric Langer Outsourcing Outlook Eric LangerOutsourcing No Longer Just for Cost-Cutting
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerSeeking Alternative Catalyst Solutions
Jill Wechsler Regulatory Watch Jill Wechsler Global Expansion Shapes Drug Oversight
Chris Burgess Statistical Solutions Chris BurgessIs a Sample Size of n=6 a Magic Number?
Sean Milmo European Regulatory WatchSean MilmoRegulating the Environmental Impact of Pharmaceuticals
Click here